AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration

Experimental and Molecular Medicine

Volumn 43, Issue 2, 2011, Pages 91-100

  Park, Kyoungsook ^a   Chung, Yong Jin ^a   So, Hyekyung ^a   Kim, Kwangsoo ^a   Park, Junsoo ^c   Oh, Mijoung ^a   Jo, Minwha ^a   Choi, Kyusam ^a   Lee, Eun Ju ^d   Choi, Yoon La ^a   Song, Sang Yong ^b   Bae, Duk Soo ^b   Kim, Byoung Gie ^b   Lee, Je Ho ^b  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Yonsei University Wonju   (South Korea)

^d Chung Ang University College of Medicine   (South Korea)

Author keywords

AGR2 protein; Biological markers; Human; Ovarian neoplasms

Indexed keywords

ANTERIOR GRADIENT 2 PROTEIN; COMPLEMENTARY DNA; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA MICROARRAY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; OVARY CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE ANALYSIS; WESTERN BLOTTING;

EID: 79952382549     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2011.43.2.011     Document Type: Article

References (25)

1. Aberger F, Weidinger G, Grunz H, Richter K. Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2. Mech Dev 1998;72: 115-30
2. American Cancer Society. Cancer facts and figures 2005 [online]. Atlanta, GA, available from: URL: http://www.cancer.org/docroot/stt/stt_0.asp
3. Aunoble B, Sanches R, Didier E, Bignon YJ. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). Int J Oncol 2000;16:567-76
4. Choi J, Choi K, Benveniste EN, Rho SB, Hong YS, Lee JH, Kim J, Park K. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. Cancer Res 2005; 65:5554-60
5. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005;97:1407-27
6. Fletcher GC, Patel S, Tyson K, Adam PJ, Schenker M, Loader JA, Daviet L, Legrain P, Parekh R, Harris AL, et al. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptorpositive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br J Cancer 2003;88:579-85
7. Fritzsche FR, Dahl E, Pahl S, Burkhardt M, Luo J, Mayordomo E, Gansukh T, Dankof A, Knuechel R, Denkert C, et al. Prognostic relevance of AGR2 expression in breast cancer. Clin Cancer Res 2006;12:1728-34
8. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70
9. Komiya T, Tanigawa Y, Hirohashi S. Cloning of the gene gob-4, which is expressed in intestinal goblet cells in mice. Biochim Biophys Acta 1999;1444:434-8
10. Kozak KR, Su F, Whitelegge JP, Faull K, Reddy S, Farias-Eisner R. Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 2005; 5:4589-96
11. Kristiansen G, Pilarsky C, Wissmann C, Kaiser S, Bruemmendorf T, Roepcke S, Dahl E, Hinzmann B, Specht T, Pervan J, et al. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J Pathol 2005;205:359-76
12. Liede A, Karlan BY, Baldwin RL, Platt LD, Kuperstein G, Narod SA. Cancer incidence in a population of Jewish women at risk of ovarian cancer. J Clin Oncol 2002;20:1570-7
13. Liu D, Rudland PS, Sibson DR, Platt-Higgins A, Barraclough, R. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res 2005;65:3796-805
14. Park K, Kim K, Rho SB, Choi K, Kim D, Oh SH, Park J, Lee SH, Lee JH. Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis. Cancer Res 2005;65:749-57
15. Park K, Choi K, Kim H, Kim K, Lee MH, Lee JH, Kim Rim JC. Isoflavone-deprived soy peptide suppresses mammary tumorigenesis by inducing apoptosis. Exp Mol Med 2009; 41:371-81
16. Park SW, Zhen G, Verhaeghe C, Nakagami Y, Nguyenvu LT, Barczak AJ, Killeen N, Erle DJ. The protein disulfide iso merase AGR2 is essential for production of intestinal mucus. Proc Natl Acad Sci USA 2009;106:6950-5
17. Ramachandran V, Arumugam T, Wang H, Logsdon CD. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res 2008;68:7811-8
18. Riener MO, Pilarsky C, Gerhardt J, Grutzmann R, Fritzsche FR, Bahra M, Weichert W, Kristiansen G. Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma. Histol Histopathol 2009;24:1121-8
19. See HT, Kavanagh JJ, Hu W, Bast RC. Targeted therapy for epithelial ovarian cancer: current status and future prospects. Int J Gynecol Cancer 2003;13:701-34
20. Sharma S, Odunsi K. Targeted therapy for epithelial ovarian cancer. Expert Opin Ther Targets 2005;9:501-13
21. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, et al. Global gene expression profiling of circulating tumor cells. Cancer Res 2005;65:4993-7
22. Wang Z, Hao Y, Lowe AW. The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation. Cancer Res 2008;68:492-7
23. Yang SH, Kim JS, Oh TJ, Kim MS, Lee SW, Woo SK, Cho HS, Choi YH, Kim YH, Rha SY, Chung HC, An SW. Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray. Int J Oncol 2003;22:741-50
24. Zhang JS, Gong A, Cheville JC, Smith DI, Young CY. AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes Cancer 2005;43: 249-59
25. Zhang Z, Bast RC Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng XY, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 2004;64:5882-90